Here are five things to know about the procedure:
1. William D. Smith, MD, performed the first two procedures at the American Institute of Minimally Invasive Surgery in Cyprus, Wyo.
2. Triadyme-C is Dymicron’s flagship product and is designed to minimize wear debris and emulate the natural constrained motion of the spine.
3. The disc replacement’s biocompatible orthopedic diamond material is made of polycrystalline diamond compact, among the hardest substances known to man. As a result, there is a low coefficient of friction, so the implant resists structural breakdown that produces debris.
4. Dymicron is slated to begin clinical studies in England, Germany and South Africa in the third quarter of 2015.
5. The disc has an articulation mechanism with three spherical lobes seated with three non-congruent, spherical pockets to generate a gentle centering force to emulate natural spinal motion.
“We are extremely pleased that we have successfully completed our first in-man procedures,” said Jeff Bennett, Dymicron’s president. “Based on our unique technology and design, we’re confident that the Triadyme-C will become a preferred option for patients suffering from cervical degenerative disc disease.”
More articles on orthopedic devices:
6 new device launches & releases
Medtronic sets its sights on China—5 things to know
Global surgical robot markets poised for rapid growth
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.